Accord Urges Justices To Reject 'Crush-Resistant' Oxy IP Row
By Adam Lidgett · June 3, 2025, 5:55 PM EDT
Accord Healthcare Inc. says the U.S. Supreme Court should reject bankrupt OxyContin maker Purdue Pharma LP's attempt to revive its legal effort to use patent laws to block the release of...
To view the full article, register now.